Exavir Therapeutics announces preclinical data demonstrating complete elimination of HIV from human cells with LNP-delivered Tat-targeted CRISPR-Cas9
November 10, 2021 07:30 ET | Exavir Therapeutics
Early candidate from XVIR-TAT series demonstrated genetic elimination of HIV and robust anti-retroviral activity with CRISPR-Cas9 based excision Exavir lipid nanoparticles (LNPs) with mRNA...
22157.jpg
CRISPR Based Therapeutics Market, 2030
September 09, 2021 08:43 ET | Research and Markets
Dublin, Sept. 09, 2021 (GLOBE NEWSWIRE) -- The "CRISPR Based Therapeutics Market by Type of Therapy, Therapeutic Approach, Therapeutic Area, and Key Geographical Regions: Industry Trends and Global...
22157.jpg
Global Oligonucleotide Synthesis Market Report 2021: Market is Poised for Explosive Growth as Gene Technology Moves into Mainstream Healthcare, Food Production and, Even, Data Storage
August 03, 2021 06:58 ET | Research and Markets
Dublin, Aug. 03, 2021 (GLOBE NEWSWIRE) -- The "Oligonucleotide Synthesis Markets - Forecasts by Oligo Length, Application, and Product - With Executive and Consultant Guides and including Customized...
22157.jpg
Global $4.75 Billion CRISPR & Cas Genes Market Analysis 2016-2019 & Forecasts 2020-2027
March 01, 2021 07:14 ET | Research and Markets
Dublin, March 01, 2021 (GLOBE NEWSWIRE) -- The "CRISPR & Cas Genes Market Size, Share & Trends Analysis Report, By Product & Service; By Application; By End Use; and By Region; Segment...
22157.jpg
Global $4.88 Bn CRISPR & Cas Genes Market to 2027: Opportunities in the Expanding Gene & Cell Therapy Area & Government Fund In Genomic R&D
September 21, 2020 05:18 ET | Research and Markets
Dublin, Sept. 21, 2020 (GLOBE NEWSWIRE) -- The "Global CRISPR & Cas Genes Market Size, Share & Trends Analysis by Product & Service (Vector-based Cas, DNA-free Cas, Cell Line...
Excision logo 2.png
CRISPR Gene Editing Eliminates Herpes Simplex Virus and JC Virus, Demonstrating Feasibility of a Potential Functional Cure
November 18, 2019 12:00 ET | Excision BioTherapeutics
Oakland, CA, Nov. 18, 2019 (GLOBE NEWSWIRE) -- At the 2019 International Symposium on Neurovirology, Excision BioTherapeutics, a gene therapy company focusing on curing viral infectious diseases,...